In vitro investigation of antifungal activity of allicin alone and in combination with azoles against Candida species

Mycopathologia

Volumn 169, Issue 4, 2010, Pages 287-295

  Khodavandi, Alireza ^a   Alizadeh, Fahimeh ^a   Aala, Farzad ^a   Sekawi, Zamberi ^a   Chong, Pei Pei ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Allicin; Antifungal activity; Candida spp.; Fluconazole; Ketoconazole

Indexed keywords

ALLICIN; ANTIFUNGAL AGENT; FLUCONAZOLE; KETOCONAZOLE; PYRROLE DERIVATIVE; SULFINIC ACID DERIVATIVE;

ARTICLE; CANDIDA; CANDIDIASIS; DRUG EFFECT; DRUG POTENTIATION; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA; CANDIDIASIS; DRUG SYNERGISM; FLUCONAZOLE; HUMANS; KETOCONAZOLE; MICROBIAL SENSITIVITY TESTS; SULFINIC ACIDS;

ALLIUM SATIVUM; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS;

EID: 77952668569     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-009-9251-3     Document Type: Article

References (40)

1. Rangel-Frausto MS, Wilblin T, Blumberg HM, Saiman L, Patterson J, Rinaldi M, et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis. 1999; 29: 253-8.
2. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T. Secular trends in nosocomial primary blood-stream infections in the United States. National Nosocomial Infections Surveillance System. Am J Med. 1991; 91(3B): S86-9.
3. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis. 1999; 29: 239-44.
4. Ng KP, Madasamy M, Saw TL, Baki A, He J, Soo-Hoo TS. Candida biotypes isolated from clinical specimens in Malaysia. Mycopathol. 1999; 144: 135-40.
5. Odds FC, Brown AJP, Gow NAR. Antifungal agents: mechanisms of action. Trends Microbiol. 2003; 11: 272-9.
6. Hemaiswaryaa S, Kruthiventib AK, Doblea M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine. 2008; 15: 639-52.
7. Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect. 1999; 2: 125-9.
8. Cai Y, Wang R, Pei F, Liang BB. Antibacterial activity of allicin alone and in combination with β -lactams against Staphylococcus spp. and Pseudomonas aeruginosa. J Antibiot. 2007; 60(5): 335-8.
9. Yamada Y, Azuma K. Evaluation of the in vitro antifungal activity of allicin. Antimicrob Agent Chemother. 1977; 11: 743-9.
10. Shen JK, Davis LE, Cai Y. Antifungal activity in human cerebrospinal fluid and plasma after intravenous administration of Allium sativum. Antimicrob Agents Chemother. 1990; 34(4): 651-3.
11. Davis SR, Perrie R, Apitz-Castro R. The in vitro susceptibility of Scedosporium prolificans to ajoene, allitridium and a raw extract of garlic (Allium sativum). J Antimicrob Chemother. 2003; 51: 593-7.
12. Tsao SM, Yin MC. In vitro antimicrobial activity of four diallyl sulphides occurring naturally in garlic and Chinese leek oils. J Med Microbiol. 2001; 50: 646-9.
13. Yoshida S, Kasuga S, Hayashi N, Ushiroguchi T, Matsuura H, Shizutoshi N. Antifungal activity of ajoene derived from garlic. Appl Environ Microbiol. 1987; 53(3): 615-7.
14. Lemar KM, Turner MP, Lloyd D. Garlic (Allium sativum) as an anti-Candida agent: a comparison of the efficacy of fresh garlic and freeze-dried extracts. J Appl Microbiol. 2002; 93: 398-405.
15. Low CF, Chong PP, Yong PVC, Lim CSY, Ahmad Z, Othman F. Inhibition of hyphae formation and SIR2 expression in Candida albicans treated with fresh Allium sativum (garlic) extract. J Appl Microbiol. 2008; 105(6): 2169-77.
16. Davis SR. An overview of the antifungal properties of allicin and its breakdown products-the possibility of a safe and effective antifungal prophylactic. Mycoses. 2005; 48: 95-100.
17. Hughes BG, Lawson DL. Antimicrobial effects of Allium sativum L. (garlic), Allium ampeloprasum (elephant garlic), and Allium cepa (onion), garlic compounds and commercial garlic supplement products. Phytother Res. 1991; 5: 154-8.
18. Feldberg RS, Chang SC, Kotik AN, Nadler M, Neuwirth Z, Sundstrom DC, Thompson NH. In vitro mechanism of inhibition of bacterial growth by allicin. Antimicrob Agents Chemother. 1988; 1763-1768.
19. MaoMao A, Hui S, YongBing C, JunDong Z, Yun C, Rui W, et al. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans. Int J Antimicrob Agents. 2009; 33: 258-63.
20. Miron T, Rabinkov A, Mirelman D, Wilchek M, Weiner L. The mode of action of allicin: its ready permeability through phospholipid membranes may contribute to its biological activity. Biochim Biophys Acta. 2000; 1463: 20-30.
21. National Committee for Clinical Laboratory Standards (NCCLS). Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard NCCLS document M27-A2. Wayne PA NCCLS. 2002; 22.
22. Sahm DF, Washington JA II. Antibacterial susceptibility tests: dilution methods. Manual of clinical microbiology. Washington DC: American Society for Microbiology; 1995.
23. George M, Eliopoulos GM, Robert C, Moellering JR. Antimicrobial combinations. Antibiotics in laboratory medicine. Baltimore: The Williams & Wilkins; 1996.
24. Lebouvier N, Pagniez F, Duflos M, Le Pape P, Na YM, Le Bauta G, et al. Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety. Bioorgan Med Chem Lett. 2007; 17: 3686-9.
25. Pereira-Cencil T, Del Bel Cury AA, Crielaard W, Ten Cate JM. Development of Candida-associated denture stomatitis: new insights. J Appl Oral Sci. 2008; 16(2): 86-94.
26. He QQ, Li K, Cao YB, Dong HW, Zhao LH, Liu CM, et al. Design, synthesis and molecular docking studies of novel triazole antifungal compounds. Chinese Chem Lett. 2007; 18: 663-6.
27. Al-Mohsen I, Hughes WT. Systemic antifungal therapy: past, present and future. Annal Saudi Med. 1998; 18: 28-38.
28. Cauffman CA, Lynch JP. Fungal pneumonia. Pulmonary/respiratory therapy secrets. In: Parsons PE, Heffner JE (eds). Philadelphia: Hauley & Belfus Inc. 2001; 173.
29. Rogers T, Galgiani JN. Activity of Fluconazole (UK 49, 858) and Ketoconazole against Candida albicans in vitro and in vivo. Antimicrob Agent Chemother. 1986; 30: 418-22.
30. Shadkchan Y, Shemesh E, Mirelman D, Miron T, Rabinkov A, Wilchek M, et al. Efficacy of allicin, the reactive molecule of garlic, in inhibiting Aspergillus spp. in vitro, and in a murine model of disseminated aspergillosis. J Antimicrob Chemother. 2004; 53: 832-6.
31. Pyun MS, Shin S. Antifungal effects of the volatile oils from Allium plants against Trichophyton species and synergism of the oils with ketoconazole. Phytomedicine. 2006; 13: 394-400.
32. Elnima EI, Ahmed SA, Mekkawi AG, Mossa JS. The antimicrobial activity of garlic and onion extracts. Pharmazie. 1983; 38: 747-8.
33. Ogita A, Hirooka K, Yamamoto Y, Tsutsui N, Fujita K, Taniguchi M, et al. Synergistic fungicidal activity of Cu2 + and allicin, an allyl sulfur compound from garlic, and its relation to the role of alkyl hydroperoxide reductase 1 as a cell surface defense in Saccharomyces cerevisiae. Toxicology. 2005; 215: 205-13.
34. Ogita A, Fujita K, Taniguchi M, Tanaka T. Dependence of synergistic fungicidal activity of Cu2 + and allicin, an allyl sulfur compound from garlic, on selective accumulation of the ion in the plasma membrane fraction via allicin-mediated phospholipid peroxidation. Planta Med. 2006; 72: 875-80.
35. Ledezmal E, Maniscalchi MT, Espinoza DL. Synergy between ajoene and ketoconazole in isolates of Microsporum canis. Rev Iberoam Micol. 2008; 25: 157-62.
36. Pfaller MA, Boyken LB, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, et al. Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance programme. J Clin Microbiol. 2008; 46(11): 3585-90.
37. Lozano-Chiu M, Arikan S, Paetznick VL, Anaissie EJ, Rex JH. Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility. J Clin Microbiol. 1999; 37: 2755-9.
38. Revankar SG, Kirkpatrick WR, McAtee RK, Fothergill AW, Redding SW, Rinaldi MG, et al. Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method. J Clin Microbiol. 1998; 36: 153-6.
39. Barry AL, Pfaller MA, Rennie RP, Fuchs PC, Brown SD. Precision and accuracy of fluconazole susceptibility testing by broth microdilution, E-test, and disk diffusion methods. Antimicrob Agents Chemother. 2002; 46(6): 1781-4.
40. Freeman F, Kodera Y. Garlic chemistry: stability of S-(2-propenyl)-2-propene-1- sulfinothionate (allicin) in blood, solvents, and simulated physiological fluids. J Agric Food Chem. 1995; 43: 2332-8.